UMB Bank n.a. Has $77,000 Stake in DENTSPLY SIRONA Inc. $XRAY

UMB Bank n.a. grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 319.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,822 shares of the medical instruments supplier’s stock after buying an additional 3,673 shares during the period. UMB Bank n.a.’s holdings in DENTSPLY SIRONA were worth $77,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at $25,000. Brooklyn Investment Group acquired a new position in DENTSPLY SIRONA in the first quarter valued at $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in DENTSPLY SIRONA during the first quarter valued at $26,000. Caitong International Asset Management Co. Ltd grew its holdings in DENTSPLY SIRONA by 8,003.6% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 2,241 shares during the period. Finally, MassMutual Private Wealth & Trust FSB raised its position in shares of DENTSPLY SIRONA by 160.2% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 2,805 shares of the medical instruments supplier’s stock worth $45,000 after acquiring an additional 1,727 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $12.37 on Friday. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The firm has a fifty day simple moving average of $14.20 and a two-hundred day simple moving average of $14.84. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $27.44. The firm has a market capitalization of $2.47 billion, a PE ratio of -2.61, a price-to-earnings-growth ratio of 0.80 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. The firm had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same period last year, the firm earned $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 5.2%. The ex-dividend date of this dividend is Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -13.50%.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Wall Street Zen lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Barrington Research cut their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating on the stock in a report on Friday, August 8th. Wells Fargo & Company reduced their price objective on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a research report on Friday, August 8th. Stifel Nicolaus dropped their target price on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating on the stock in a research report on Friday, August 8th. Finally, Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a report on Monday, July 21st. Two research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $18.64.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.